Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease.

optical coherence tomography optical coherence tomography angiography parkinson's disease retina vascularization

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 07 02 2020
accepted: 24 08 2020
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 30 10 2020
Statut: epublish

Résumé

A thinning of intraretinal layers has been previously described in Parkinson's disease (PD) patients compared to healthy controls (HCs). Few studies evaluated the possible correlation between retinal thickness and retinal microvascularization. Thus, here we assessed the thickness of retinal layers and microvascular pattern in early PD patients and HCs, using, respectively, spectral-domain optical coherence tomography (SD-OCT) and SD-OCT-angiography (SD-OCT-A), and more interestingly, we evaluated a possible correlation between retinal thickness and microvascular pattern. Patients fulfilling criteria for clinically established/clinically probable PD and HCs were enrolled. Exclusion criteria were any ocular, retinal, and systemic disease impairing the visual system. Retinal vascularization was analyzed using SD-OCT-A, and retinal layer thickness was assessed using SD-OCT. Forty-one eyes from 21 PD patients and 33 eyes from 17 HCs were evaluated. Peripapillary retinal nerve fiber layer (RNFL) and macular RNFL, ganglionic cell layer (GCL), inner plexiform layer (IPL), and inner nuclear layer (INL), resulted to be thinner in PD compared to HCs. Among PD patients, a positive correlation between RNFL, GCL, and IPL thickness and microvascular density was found in the foveal region, also adjusting by age, sex, and, especially, hypertension. Such findings were already present in the early stage of disease and were irrespective of dopaminergic treatment. Thus, the retina might be considered a biomarker of PD and could be a useful instrument for onset and disease progression.

Identifiants

pubmed: 33117254
doi: 10.3389/fneur.2020.533375
pmc: PMC7575742
doi:

Types de publication

Journal Article

Langues

eng

Pagination

533375

Informations de copyright

Copyright © 2020 Rascunà, Russo, Terravecchia, Castellino, Avitabile, Bonfiglio, Fallico, Chisari, Cicero, Grillo, Longo, Luca, Mostile, Zappia, Reibaldi and Nicoletti.

Références

Parkinsonism Relat Disord. 2020 May;74:57-63
pubmed: 32335490
Sci Rep. 2016 Jul 08;6:29523
pubmed: 27389831
Mov Disord. 1992;7(3):232-8
pubmed: 1620141
Life Sci. 1988;43(3):255-62
pubmed: 3260986
J Ophthalmol. 2016;2016:8503859
pubmed: 27840739
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4115-4122
pubmed: 30098201
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
J Neural Transm (Vienna). 2013 May;120(5):745-53
pubmed: 23263598
Neurol Sci. 2013 May;34(5):683-7
pubmed: 22678179
Lancet. 2006 Jul 29;368(9533):387-403
pubmed: 16876668
Int J Epidemiol. 1989 Jun;18(2):451-6
pubmed: 2767862
Parkinsonism Relat Disord. 2019 Jul;64:40-49
pubmed: 31054866
BMJ Open. 2016 May 06;6(5):e009658
pubmed: 27154474
Mov Disord. 2004 Sep;19(9):1020-8
pubmed: 15372591
Arch Ophthalmol. 2009 Jun;127(6):737-41
pubmed: 19506190
Mov Disord. 2010 Oct 30;25(14):2461-2
pubmed: 20669291
Vision Res. 1997 Dec;37(24):3509-29
pubmed: 9425527
J Parkinsons Dis. 2015;5(4):821-36
pubmed: 26444086
Int J Epidemiol. 1996 Feb;25(1):146-51
pubmed: 8666484
Parkinsonism Relat Disord. 2013 Jan;19(1):1-14
pubmed: 22998939
Cell Tissue Res. 2004 Oct;318(1):121-34
pubmed: 15338272
Eur J Neurol. 2013 Jan;20(1):198-201
pubmed: 22436028
PLoS One. 2013;8(1):e54822
pubmed: 23359811
J Comp Neurol. 1982 Sep 1;210(1):65-79
pubmed: 6127354
Neurology. 2015 Nov 3;85(18):1569-77
pubmed: 26446068
Mov Disord. 2011 Nov;26(13):2387-95
pubmed: 21953737
Mov Disord. 2018 Mar;33(3):347-348
pubmed: 29436737
Acta Neuropathol. 2019 Mar;137(3):379-395
pubmed: 30721408
Surg Radiol Anat. 1988;10(2):137-44
pubmed: 3135618
Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2473-5
pubmed: 2243012
Neurology. 2018 Sep 11;91(11):e1003-e1012
pubmed: 30111550
Brain Pathol. 2013 Mar;23(2):154-64
pubmed: 22897695
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Lancet Neurol. 2009 Dec;8(12):1150-7
pubmed: 19909913
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Am J Ophthalmol. 2014 Feb;157(2):470-478.e2
pubmed: 24315296
Mov Disord. 2002 Jul;17(4):775-81
pubmed: 12210875
Front Neurol. 2019 Jan 15;9:1191
pubmed: 30697187
Neurology. 2010 Nov 9;75(19):1717-25
pubmed: 21060094
Mov Disord. 2018 Aug;33(8):1315-1324
pubmed: 29737566
J Neurol. 2019 Sep;266(9):2103-2111
pubmed: 30209648
Percept Mot Skills. 1995 Dec;81(3 Pt 1):931-8
pubmed: 8668456
Mov Disord. 1994 Sep;9(5):563-70
pubmed: 7990852
Mov Disord. 2010 Aug 15;25(11):1590-6
pubmed: 20623771
Neurodegener Dis. 2014;14(1):1-17
pubmed: 24080741
Br J Ophthalmol. 2014 Mar;98(3):350-5
pubmed: 24276697
Nat Rev Neurol. 2009 Oct;5(10):533-41
pubmed: 19724249
Neurology. 1992 Apr;42(4):887-90
pubmed: 1565248
Surv Ophthalmol. 2001 May-Jun;45(6):531-48
pubmed: 11425359
Front Aging Neurosci. 2019 Feb 08;11:21
pubmed: 30800065

Auteurs

Cristina Rascunà (C)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Andrea Russo (A)

Department of Ophthalmology, University of Catania, Catania, Italy.

Claudio Terravecchia (C)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Niccolò Castellino (N)

Department of Ophthalmology, University of Catania, Catania, Italy.

Teresio Avitabile (T)

Department of Ophthalmology, University of Catania, Catania, Italy.

Vincenza Bonfiglio (V)

Department of Ophthalmology, University of Catania, Catania, Italy.

Matteo Fallico (M)

Department of Ophthalmology, University of Catania, Catania, Italy.

Clara Grazia Chisari (CG)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Calogero Edoardo Cicero (CE)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Marco Grillo (M)

Department of Ophthalmology, University of Catania, Catania, Italy.

Antonio Longo (A)

Department of Ophthalmology, University of Catania, Catania, Italy.

Antonina Luca (A)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Giovanni Mostile (G)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Mario Zappia (M)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Michele Reibaldi (M)

Department of Ophthalmology, University of Catania, Catania, Italy.

Alessandra Nicoletti (A)

Section of Neurosciences, Department of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.

Classifications MeSH